Dogwood Wealth Management LLC
Position in TNXP — Tonix Pharmaceuticals Holding Corp.
CIK 2056922
LENEXA, KS
Position in TNXP
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$1,403
-$109 QoQ
Shares Held
110
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 6 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dogwood Wealth Management LLC holds $110,687 across 22 Biotechnology names. TNXP ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50 | $24,836 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30 | $9,030 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
39 | $7,303 | |
| 5 | RPRX |
Royalty Pharma plc
|
95 | $5,326 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
9 | $4,832 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
59 | $4,809 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
80 | $4,363 |
All Filings in TNXP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,403 | 110 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $1,512 | 110 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,718 | 110 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,657 | 110 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||